MOYOM Biotech hosts European clinical exchange in Shanghai
MOYOM Biotech’s regenerative aesthetics brand, aphranel, has launched a week-long clinical exchange program in Shanghai for European physicians to study Chinese medical practices.
European medical professionals have arrived in Shanghai to participate in a clinical exchange program hosted by aphranel, the regenerative aesthetics division of MOYOM Biotech. The week-long initiative focuses on analyzing contemporary Chinese clinical practices within the aesthetic sector and evaluating their potential integration into European healthcare frameworks.
The program, titled 'The Norns' Weave,' includes workshops and clinical observations aimed at facilitating knowledge transfer between markets. Participants are examining current protocols used in China to identify procedural efficiencies and outcomes that could influence future treatment standards abroad.
This exchange reflects a broader trend of cross-border medical collaboration in the aesthetic industry as firms seek to standardize outcomes and share technical expertise globally. MOYOM Biotech expects the findings from this week to inform future clinical training modules for its European partners.